These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2939597)

  • 21. [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice].
    Wang SB; Guo KY; Hu DM; Yin B
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):810-3. PubMed ID: 16793606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
    Brochu S; Baron C; Hétu F; Roy DC; Perreault C
    J Immunol; 1995 Dec; 155(11):5104-14. PubMed ID: 7594519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloned natural suppressor cells prevent lethal graft-vs-host disease.
    Strober S; Palathumpat V; Schwadron R; Hertel-Wulff B
    J Immunol; 1987 Feb; 138(3):699-703. PubMed ID: 2949006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanism of reduction of cell-mediated cytotoxicity in neonatally thymectomized mice.
    Kawauchi H; Taniguchi K; Kubo C; Shimamoto Y; Nomoto K
    Immunology; 1983 Oct; 50(2):199-205. PubMed ID: 6225727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M; Ikarashi Y; Iizuka A; Kawakami C; Quinn G; Heike Y; Yoshida M; Asaka M; Takaue Y; Wakasugi H
    Immunol Lett; 2006 Jul; 106(1):82-90. PubMed ID: 16806496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.
    Gillis S; Smith KA; Watson J
    J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloned natural suppressor cells derived from the neonatal spleen: in vitro action and lineage.
    Schwadron RB; Strober S
    Transplant Proc; 1987 Feb; 19(1 Pt 1):533-5. PubMed ID: 2978921
    [No Abstract]   [Full Text] [Related]  

  • 28. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
    Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
    Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs.
    Porter SB; Liu B; Rogosheske J; Levine BL; June CH; Kohl VK; Wagner JE; Miller JS; Blazar BR
    Transplantation; 2006 Jul; 82(1):23-9. PubMed ID: 16861937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
    Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
    J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers.
    Schlegel PG; Vaysburd M; Chen Y; Butcher EC; Chao NJ
    J Immunol; 1995 Oct; 155(8):3856-65. PubMed ID: 7561092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
    J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.
    Tsuchiya Y; Igarashi M; Suzuki R; Kumagai K
    J Immunol; 1988 Jul; 141(2):699-708. PubMed ID: 2968407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-independent activation of cytotoxic T cells by lymphokines.
    Williams LD; McMaster WR; Teh HS
    Immunology; 1988 May; 64(1):121-8. PubMed ID: 3133307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo administration of interleukin 2 stimulates mitosis in thymus and bone marrow.
    Gearing AJ; Wadhwa M; Perris AD
    Eur J Immunol; 1986 Sep; 16(9):1171-4. PubMed ID: 3093248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of a soluble nonspecific suppressor factor in the serum early after birth.
    Knaan-Shanzer S; Rombouts WJ; Westerman Y; Wagemaker G; van Bekkum DW
    Cell Immunol; 1993 Oct; 151(1):196-217. PubMed ID: 8402928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Demonstration of the lymphokine mechanism of the reinforcement of lymphoid proliferation during liver regeneration in mice].
    Rakhmilevich AL
    Ontogenez; 1989; 20(2):192-8. PubMed ID: 2525697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a human T-cell hybridoma producing an MLR suppressing factor: relationship to the mechanism of action of donor-specific transfusion.
    Haisa M; Sakagami K; Orita K
    Transplant Proc; 1990 Aug; 22(4):1977-80. PubMed ID: 2143868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.